How does dipyridamole inhibit platelet aggregation through its effect on adenosine uptake?

Dipyridamole inhibits adenosine uptake into erythrocytes, platelets and endothelial cells, increasing local adenosine, which activates platelet A2 receptors and stimulates adenylate cyclase to increase platelet cAMP, thereby inhibiting platelet aggregation.